FDA Inspection 1219018 — Viatris, Inc.
The FDA completed an inspection of Viatris, Inc. on Aug 18, 2023 in Morgantown, WV. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 18, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Morgantown, WV (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)